Home » Topics » Regulatory » Patents

Patents
RSS

Celgene identifies antiproliferative compounds for AML

Aug. 2, 2017

French researchers patent compounds for treating cancer

Aug. 2, 2017

Chemerin receptor antagonists presented by Shenzhen Institute of Advanced Technology

Aug. 1, 2017

Bayer discloses soluble guanylate cyclase activators

Aug. 1, 2017

Sperovie Biosciences patents PDE4B and/or TNF-alpha release inhibitors

July 31, 2017

Adenosine A3 receptor antagonists identified at Handok

July 31, 2017

Guangzhou Henovcom Bioscience discovers FXR agonists

July 31, 2017

Sophia Bioscience divulges histone deacetylase inhibitors

July 31, 2017

Hua Medicine patents mGlu5 receptor antagonists

July 31, 2017

Mutant EGFR and/or HER2 inhibitors presented by Ancureall Biomedical Technology

July 31, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...